Relapsed or Refractory Hodgkin Lymphoma (rrHL) Hodgkin Disease
Conditions
Interventions
Patients with RRHL who are managed in the participating centers and who meet the eligibility criteria will be included in the study.
Treatment
RRHL patients
Sponsors
Takeda (Thailand), Ltd.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with RRHL 2. Age 18 years and above at diagnosis of rrHL 3. Received at least two .of BV prior to the date of site initiation and stopped or discontinued BV at the time of data extraction
Exclusion criteria
Exclusion criteria: 1. Patients who have participated in an interventional clinical trial at any stage of their treatment of rrHL 2. Patients who are on BV treatment at the time of chart data extraction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival (PFS) From first received treatment to first documentation of relapse or disease progression or death, censored at date of site initiation Length of time (month) | — |
Secondary
| Measure | Time frame |
|---|---|
| patient demographic and clinical characteristics At enrollment Case record form | — |
Countries
Thailand
Contacts
Public ContactDr.Suporn Chuncharunee
Ramathibodi Hospital
Outcome results
None listed